Literature DB >> 2009349

Controlled silver-releasing polymers and their potential for urinary tract infection control.

T Gilchrist1, D M Healy, C Drake.   

Abstract

Calcium phosphate controlled release glass has been developed as a biocompatible vehicle for the sustained delivery of antibacterial silver ions. The solution rate in the presence of physiological fluids can be made constant over the design life of the product and one application in urinary tract infection control is outlined.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2009349     DOI： 10.1016/0142-9612(91)90136-x

Source DB:  PubMed          Journal:  Biomaterials        ISSN： 0142-9612            Impact factor:   12.479


  5 in total

1.  Soft tissue response to glycerol-suspended controlled-release glass particulate.

Authors:  S H Cartmell; P J Doherty; J A Hunt; D M Healy; T Gilchrist
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

2.  Haemocompatiblity of controlled release glass.

Authors:  S H Cartmell; P J Doherty; N P Rhodes; J A Hunt; D M Healy; T Gilchrist
Journal:  J Mater Sci Mater Med       Date:  1998-01       Impact factor: 3.896

3.  A reversible fluorescent probe for monitoring Ag(I) ions.

Authors:  Zelong Lim; David G Smith; Jacek L Kolanowski; Rebecca L Mattison; Jonathan C Knowles; Song-Yi Baek; Wojciech Chrzanowski; Elizabeth J New
Journal:  J R Soc Interface       Date:  2018-07       Impact factor: 4.118

4.  Effect of silver content on the structure and antibacterial activity of silver-doped phosphate-based glasses.

Authors:  Sabeel P Valappil; David M Pickup; Donna L Carroll; Chris K Hope; Jonathan Pratten; Robert J Newport; Mark E Smith; Michael Wilson; Jonathan C Knowles
Journal:  Antimicrob Agents Chemother       Date:  2007-10-01       Impact factor: 5.191

5.  In-vitro anticancer and antimicrobial activities of PLGA/silver nanofiber composites prepared by electrospinning.

Authors:  Fahad N Almajhdi; H Fouad; Khalil Abdelrazek Khalil; Hanem M Awad; Sahar H S Mohamed; T Elsarnagawy; Ahmed M Albarrag; Fawzi F Al-Jassir; Hany S Abdo
Journal:  J Mater Sci Mater Med       Date:  2013-12-31       Impact factor: 3.896
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.